Coeptis Therapeutics Holdings Inc (NASDAQ: COEP) is -73.59% lower on its value in year-to-date trading and has touched a low of $0.15 and a high of $1.33 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The COEP stock was last observed hovering at around $0.21 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.21, the stock is 0.40% and 8.73% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.1 million and changing -0.38% at the moment leaves the stock -32.24% off its SMA200. COEP registered -79.71% loss for a year compared to 6-month loss of -43.44%. The firm has a 50-day simple moving average (SMA 50) of $0.1902 and a 200-day simple moving average (SMA200) of $0.30726.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 16.49% gain in the last 1 month and extending the period to 3 months gives it a 2.48%, and is 3.50% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.15% over the week and 11.25% over the month.
Coeptis Therapeutics Holdings Inc (COEP) has around 7 employees, a market worth around $8.51M and $0.00M in sales. Distance from 52-week low is 37.00% and -84.44% from its 52-week high. The company has generated returns on investments over the last 12 months (-220.57%).
Coeptis Therapeutics Holdings Inc quarterly earnings per share for the current quarter are estimated at 0.0.
17.0 institutions hold shares in Coeptis Therapeutics Holdings Inc (COEP), with institutional investors hold 5.19% of the company’s shares. The shares outstanding are 35.33M, and float is at 28.42M with Short Float at 0.43%. Institutions hold 4.20% of the Float.
Coeptis Therapeutics Holdings Inc (COEP) Insider Activity
The most recent transaction is an insider purchase by Cogley Brian, the company’s Chief Financial Officer. SEC filings show that Cogley Brian bought 5,000 shares of the company’s common stock on Jan 10 ’24 at a price of $0.67 per share for a total of $3350.0. Following the purchase, the insider now owns 30000.0 shares.
Coeptis Therapeutics Holdings Inc disclosed in a document filed with the SEC on Jan 12 ’24 that DeSilva Tara (Director) bought a total of 2,266 shares of the company’s common stock. The trade occurred on Jan 12 ’24 and was made at $0.58 per share for $1305.0. Following the transaction, the insider now directly holds 32266.0 shares of the COEP stock.
Still, SEC filings show that on Jan 05 ’24, Yerace Daniel Alexander (VP of Operations) acquired 10,850 shares at an average price of $0.69 for $7486.0. The insider now directly holds 1,071,455 shares of Coeptis Therapeutics Holdings Inc (COEP).
